Prosecution Insights
Last updated: October 04, 2026

Ming Young Biomedical Corp.

1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready

Analysis

Ming Young Biomedical Corp. currently has 1 pending office action in its patent portfolio. This single matter is assigned to 1 distinct examiner, RALIS, STEPHEN J, who is responsible for the entirety of the company's active prosecution. The workload is concentrated within 1 distinct art unit, showing the administrative path for the company's intellectual property filings.

RALIS, STEPHEN J is identified as the busiest examiner for this portfolio, currently overseeing 1 pending office action. This level of concentration means that the company's legal strategy is tied to the specific examination tendencies of a single individual. There are no other examiners or art units currently involved in the company's pending matters. The focus of the current filings is managed through this single administrative channel.

For a practitioner, this data highlights a prosecution environment with a single point of contact. The outcome of the active office action will define the immediate success of the portfolio. Because only 1 distinct examiner and 1 distinct art unit are involved, there is no need to navigate varying procedural styles or conflicting interpretations of patent law. The focus remains entirely on the interaction with RALIS, STEPHEN J.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Portfolio Summary

1
Total Pending OAs
1
Non-Final OAs
0
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
0
Due this month
0
Due in next 60 days
0
Due later

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

1
Hard (100%)
0
Medium (0%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
Multi-statute (no §101)1 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
0
Mechanical / Eng
0% of docket
1
Business / Other
100% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

10 h
Manual time on pending OAs
2 h
Time saved (low, 20%)
4 h
Time saved (mid, 35%)
0.1 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
RALIS, STEPHEN J 1 33.5% +42.3%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18220018 PRODUCT, METHOD AND SYSTEM FOR MONITORING PHYSIOLOGICAL FUNCTION AND POSTURE RALIS, STEPHEN J 96d overdue

Interview Candidates (1)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18220018 PRODUCT, METHOD AND SYSTEM FOR MONITORING PHYSIOLOGICAL FUNCTION AND POSTURE RALIS, STEPHEN J 96d overdue

Top Art Units

Art UnitApps
3992 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
18220018 PRODUCT, METHOD AND SYSTEM FOR MONITORING PHYSIOLOGICAL FUNCTION AND POSTURE RALIS, STEPHEN J 3992 §103§112Other Non-Final OA 96d overdue Pending Jul 10, 2023

Managing Ming Young Biomedical Corp.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month